AGALAX-S
AGALAX-S
Authorised
- Mycoplasma agalactiae, Inactivated
- Mycoplasma capricolum, Inactivated
- Mycoplasma mycoides subsp. mycoides, Inactivated
Product identification
Medicine name:
Агалакс С
AGALAX-S
Active substance:
- Mycoplasma agalactiae, Inactivated
- Mycoplasma capricolum, Inactivated
- Mycoplasma mycoides subsp. mycoides, Inactivated
Target species:
-
Sheep
-
Goat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Mycoplasma agalactiae, Inactivated10.00log10 colony forming unit(s)2.00millilitre(s)
-
Mycoplasma capricolum, Inactivated10.00log10 colony forming unit(s)2.00millilitre(s)
-
Mycoplasma mycoides subsp. mycoides, Inactivated10.00log10 colony forming unit(s)2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Sheep
- Goat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI03AB
- QI04AB
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Available in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Syva S.A.U.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-1804
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 30/01/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 30/01/2024
How useful was this page?: